Header and Body 4


  • Generic separation technique can be used on many target contaminants
  • Highly selective separation—nanoparticles do not bind mammalian cells
  • Rapid incubation and separation—minimizes the time blood spends outside the body, reducing risk of coagulation and contamination
  • Synthetic ligands are stable, inexpensive, and straightforward to synthesize
  • Compatible with existing clinical blood-modifying technologies (e.g., hemodialysis)